Placental microparticles, DNA, and RNA in preeclampsia

scientific article published on 21 December 2010

Placental microparticles, DNA, and RNA in preeclampsia is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3109/10641951003599571
P698PubMed publication ID21174588

P2093author name stringSinuhe Hahn
Corinne Rusterholz
Irene Hoesli
Marianne Messerli
P2860cites workTHE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIAQ56001888
Presence of fetal DNA in maternal plasma and serumQ57075132
Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsiaQ57671390
Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restrictionQ58623928
Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic reviewQ28196410
Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsiaQ28304349
Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal PlasmaQ28314918
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communicationQ29615670
Down syndrome and cell-free fetal DNA in archived maternal serum.Q31119002
Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionationQ33274418
Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosisQ34107990
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.Q34385131
Rapid clearance of fetal DNA from maternal plasmaQ34388637
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.Q34514153
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsiaQ34635362
Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia?Q34648192
Noninvasive prenatal diagnosis: current practice and future perspectivesQ34767863
mRNA of placental origin is readily detectable in maternal plasma.Q34960254
Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a reviewQ35169648
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA.Q35221979
Cellular microparticles: new players in the field of vascular disease?Q35807312
Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolutionQ35810254
Fetal cell-free nucleic acids in the maternal circulation: new clinical applicationsQ35835705
Apoptosis and its role in the trophoblastQ36437226
Disturbances in placental immunology: ready for therapeutic interventions?Q36494229
Beneficial suicide: why neutrophils die to make NETsQ36882473
Placental origins of preeclampsia: challenging the current hypothesisQ37079631
The two stage model of preeclampsia: variations on the themeQ37187589
Potential markers of preeclampsia--a reviewQ37278804
Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genesQ38287698
Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction--a pilot studyQ40588231
Preeclampsia: an excessive maternal inflammatory response to pregnancyQ40824430
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trialsQ40970723
Preeclampsia: an endothelial cell disorderQ41281924
Leukocyte adhesion molecules and reactive oxygen species in preeclampsiaQ42461058
Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicismQ43073795
Folic acid supplementation in early second trimester and the risk of preeclampsiaQ44054579
Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulationQ44302005
Gene expression profiling of human placentas from preeclamptic and normotensive pregnanciesQ44440966
Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasmaQ47391690
Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphismsQ47423342
Size distributions of maternal and fetal DNA in maternal plasma.Q47432593
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.Q47889241
Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia.Q51055687
Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts.Q51191119
Soluble factors released by placental villous tissue: Interleukin-1 is a potential mediator of endothelial dysfunction.Q51543784
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.Q51767524
Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy.Q51836356
Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.Q52237839
Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines.Q53645062
Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.Q54459706
Preparation of human placental villous surface membrane.Q54606446
High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery.Q54648888
Earliest gestational age for fetal sexing in cell-free maternal plasma.Q54736349
The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia.Q54777020
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmaternal healthQ6786626
pre-eclampsiaQ61335
P304page(s)364-375
P577publication date2010-12-21
P1433published inHypertension in PregnancyQ5958696
P1476titlePlacental microparticles, DNA, and RNA in preeclampsia
P478volume30

Reverse relations

cites work (P2860)
Q28069689A Dormant Microbial Component in the Development of Preeclampsia
Q40544172Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes
Q38213813Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review
Q35390255Cellular fetal microchimerism in preeclampsia
Q57300007Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?
Q28081459Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia
Q47550799Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father
Q38172587MicroRNAs: are they the missing link between hypoxia and pre-eclampsia?
Q36847554Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners
Q37715713Stimulation of monocytes by placental microparticles involves toll-like receptors and nuclear factor kappa-light-chain-enhancer of activated B cells
Q38116097Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis.

Search more.